Breslin Cancer Center at Ingham Regional Medical Center — East Lansing, Michigan

Breslin Cancer Center at Ingham Regional Medical Center is a clinical research site located in East Lansing, Michigan, United States 48824-1313.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Breslin Cancer Center at Ingham Regional Medical Center has participated in 2 clinical trials.

Therapeutic areas: Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer.

Sponsors: SWOG Cancer Research Network, Children's Oncology Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in East Lansing

Browse all research sites in Michigan · View every site in East Lansing

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Breslin Cancer Center at Ingham Regional Medical Center?

Breslin Cancer Center at Ingham Regional Medical Center has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Breslin Cancer Center at Ingham Regional Medical Center conducted?

Breslin Cancer Center at Ingham Regional Medical Center has 2 clinical trials on record. Their work covers Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer.

Is Breslin Cancer Center at Ingham Regional Medical Center accredited by Crixeo Clinical Trials?

Breslin Cancer Center at Ingham Regional Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Breslin Cancer Center at Ingham Regional Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.